pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
545
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 3
milvexian
Acute Ischemic Stroke
Coagulation factor XI
Bristol-Myers Squibb Co
0
catalysts
Phase 3
mirodenafil dihydrochloride
Alzheimer's Disease
AriBio Co Ltd
0
catalysts
Phase 3
mivocabtagene autoleucel
mivocabtagene autoleucel [INN]
Myasthenia Gravis
$KYTX
Kyverna Therapeutics, Inc.
0
catalysts
← prev
page 13 of 19
next →
131
Pain
89
Neurology
1
Phase 3
mocravimod hydrochloride
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Priothera Ltd
0
catalysts
Phase 3
monepantel
monepantel [INN]
Amyotrophic Lateral Sclerosis
Neurizon Therapeutics Ltd
0
catalysts
Phase 3
nadunolimab
nadunolimab [INN]
Pancreatic Ductal Adenocarcinoma
Cantargia AB
0
catalysts
Phase 3
namodenoson
Hepatocellular Carcinoma
Adenosine receptor A3
$CANF
Can-Fite BioPharma Ltd.
0
catalysts
Phase 3
nanvuranlat
nanvuranlat [INN]
Metastatic Biliary Tract Cancer
J-Pharma Co Ltd
0
catalysts
Phase 3
napazimone
Mitochondrial Diseases
Abliva AB
0
catalysts
Phase 3
navacaprant hydrochloride
Major Depressive Disorder
$NMRA
Neumora Therapeutics, Inc.
0
catalysts
Phase 3
navenibart
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
$BCRX
BIOCRYST PHARMACEUTICALS INC
0
catalysts
Phase 3
navitoclax dihydrochloride
Myelofibrosis
$ABBV
AbbVie Inc.
0
catalysts
Phase 3
naxtarubicin
Refractory Acute Myeloid Leukemia
$MBRX
Moleculin Biotech, Inc.
0
catalysts
Phase 3
neridronic acid
neridronic acid [INN]
Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathet…
Ambros Therapeutics Inc
0
catalysts
Phase 3
nerinetide
Acute Ischemic Stroke
NoNO Inc
0
catalysts
Phase 3
nexiguran ziclumeran
Familial Amyloid Cardiomyopathy
$REGN
REGENERON PHARMACEUTICALS, INC.
0
catalysts
Phase 3
nibrozetone
Small-Cell Lung Cancer
EpicentRx Inc
0
catalysts
Phase 3
nintedanib
NINTEDANIB (nintedanib)
Pterygium
Platelet-derived growth factor receptor
Vascular endothelial growth factor receptor
Cloudbreak Therapeutics LLC
0
catalysts
Phase 3
nivolumab biosimilar
Bladder Cancer
Xbrane Biopharma AB
0
catalysts
Phase 3
nizubaglustat
nizubaglustat [INN]
GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency)
Azafaros BV
0
catalysts
Phase 3
nofazinlimab
nofazinlimab [INN]
Hepatocellular Carcinoma
CStone Pharmaceuticals Co Ltd
0
catalysts
Phase 3
norelgestromin
Female Contraception
Progesterone receptor
$VTRS
Viatris Inc
0
catalysts
Phase 3
nucresiran
nucresiran [INN]
Familial Amyloid Cardiomyopathy
$ALNY
ALNYLAM PHARMACEUTICALS, INC.
0
catalysts
Phase 3
obecabtagene autoleucel
Aucatzyl (obecabtagene autoleucel)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
B-lymphocyte antigen CD19
$AUTL
Autolus Therapeutics plc
0
catalysts
Phase 3
obefazimod
Ulcerative Colitis
Cap binding complex
Abivax SA
0
catalysts
Phase 3
obexelimab
Immunoglobulin G4-Related Disease (IgG4-RD)
B-lymphocyte antigen CD19
Low affinity immunoglobulin gamma Fc region receptor II-b
$ZBIO
Zenas BioPharma, Inc.
0
catalysts
Phase 3
obicetrapib calcium
Heterozygous Familial Hypercholesterolemia (heFH)
NewAmsterdam Pharma Company NV
0
catalysts
Phase 3
obudanersen sodium
Angelman Syndrome
$IONS
IONIS PHARMACEUTICALS INC
0
catalysts
Phase 3
ocrelizumab biosimilar
Relapsing Remitting Multiple Sclerosis (RRMS)
Celltrion Inc
0
catalysts
Phase 3
odronextamab
Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue o…
B-lymphocyte antigen CD20
T cell surface glycoprotein CD3
$REGN
REGENERON PHARMACEUTICALS, INC.
0
catalysts
